Rankings
▼
Calendar
DFTX FY 2015 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DFTX
Definium Therapeutics, Inc.
$2B
FY 2015 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$94,550
Net Income
-$92,656
EPS (Diluted)
$-1.17
Cash Flow
Operating Cash Flow
-$46,559
Free Cash Flow
-$46,559
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$291,656
Total Liabilities
$7,485
Stockholders' Equity
$284,171
Cash & Equivalents
$4,622
← FY 2016
All Quarters
